Skip to Content

Parnassus Mid Cap Growth Investor PARNX

Medalist Rating as of | See Parnassus Investment Hub
  • NAV / 1-Day Return 58.61  /  +0.55 %
  • Total Assets 867.7 Mil
  • Adj. Expense Ratio
    0.800%
  • Expense Ratio 0.800%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Mid-Cap Growth
  • Investment Style Mid Growth
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield
  • Turnover 47%

USD | NAV as of Feb 23, 2024 | 1-Day Return as of Feb 23, 2024, 11:18 PM GMT+0

Morningstar’s Analysis PARNX

Will PARNX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Parnassus Updates ESG Exclusions; Ratings Unchanged

null Stephen Welch

Stephen Welch

Analyst Note

Parnassus announced that the firm removed its long-held nuclear power exclusion for firm holdings as of May 1, 2023. To support the transition to a low-carbon economy, the firm felt it necessary to remove its nuclear power exclusion. It will still emphasize reputational and material ESG risk assessments of its potential investments. This expands the firm's universe by roughly 20 companies, mainly utilities. There are no other changes to the firm's investment approach, and we do not expect this change to materially impact the portfolio characteristics or holdings. It does not change Parnassus funds' Morningstar Medalist Ratings.

Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PARNX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 34.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Guidewire Software Inc

5.07 41.4 Mil
Technology

Equifax Inc

3.60 29.3 Mil
Industrials

CoStar Group Inc

3.56 29.1 Mil
Real Estate

Agilent Technologies Inc

3.44 28.1 Mil
Healthcare

Fortinet Inc

3.39 27.7 Mil
Technology

Ross Stores Inc

3.29 26.8 Mil
Consumer Cyclical

Morningstar Inc

3.24 26.5 Mil
Financial Services

Cintas Corp

3.19 26.0 Mil
Industrials

IDEXX Laboratories Inc

3.09 25.2 Mil
Healthcare

MercadoLibre Inc

3.04 24.8 Mil
Consumer Cyclical